Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Phase III Study Comparing FTD/TPI Therapy Versus Placebo in Patients Who Are Positive for Blood Circulating Tumor DNA After Curative Resection of Colorectal Cancer

NCT04457297 is registered in ClinicalTrials.gov with National Cancer Center Hospital East as lead sponsor.

NCT NCT04457297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04457297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Phase III Study Comparing FTD/TPI Therapy Versus Placebo in Patients Who Are Positive for Blood Circulating Tumor DNA After Curative Resection of Colorectal Cancer
Lead sponsor
National Cancer Center Hospital East
Phase
Phase 3
Overall status
Completed
Start date
July 8, 2020
Completion date
July 18, 2024
Enrollment
243 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

circulating tumor dna, colorectal neoplasms, trifluridine and tipiracil